Genentech secures FDA approval to trial Actemra for Covid-19

Multiple independent studies are being conducted worldwide to assess Actemra in patients with Covid-19 pneumonia. Credit: F. Hoffmann-La Roche Ltd.



  • Actemra; tocilizumab